U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

  1. Home
  2. About FDA
  3. FDA Organization
  4. Office of the Commissioner
  5. Office of the Chief Scientist
  6. Office of Regulatory and Emerging Science
  1. Office of the Chief Scientist

Office of Regulatory and Emerging Science

ORES provides strategic leadership, coordination, and support for innovation in FDA’s regulatory science and preparedness research to advance FDA’s ability to protect and promote public health.

Image
scientific collage with scientists, syringe, viruses, vaccine, microscope, and small group

Vision

A regulatory ecosystem that promotes and readily leverages advances in science and technology to protect and promote public health.

Mission

To further regulatory science, training, and engagement that supports the application of advances in science and technology to the development, viability, availability, and sustainability of FDA-regulated products.


Major Functions

ORES provides strategic leadership, coordination, and support for innovation in the U.S. Food and Drug Administration's (FDA) regulatory science and preparedness research to advance FDA’s ability to protect and promote public health in the following program areas:

What's New

Apply for Funding – The application process for FY25 funding under the FDA Broad Agency Announcement (BAA) is now open. Submit your research and development proposals to support regulatory science and innovation by February 24, 2025. Get details at Sam.gov and plan to attend FDA BAA Day on November 14, 2024.

Program Areas

Contact us: ORES@fda.hhs.gov




Back to Top